Arama Sonuçları - Ana Maluenda

  • Gösterilen 1 - 4 sonuçlar arası kayıtlar. 4
Sonuçları Daraltın
  1. 1
    An Ultrasound‐Responsive Theranostic Cyclodextrin‐Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis

    An Ultrasound‐Responsive Theranostic Cyclodextrin‐Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis Yazar: Sourabh Mehta, Viktoria Bongcaron, Tien Nguyen, Yugandhara Jirwanka, Ana Maluenda, Aidan P. G. Walsh, Jathushan Palasubramaniam, Mark D. Hulett, Rohit Srivastava, Alex Bobik, Xiaowei Wang, Karlheinz Peter

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injury

    α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injury Yazar: Maria Wallert, M. Ziégler, Xiaowei Wang, Ana Maluenda, Xiaoqiu Xu, May Lin Yap, Roman Witt, Corey Giles, Stefan Kluge, Marcus Hortmann, Jianxiang Zhang, Peter J. Meikle, Stefan Lorkowski, Karlheinz Peter

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque

    Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque Yazar: Imran Rashid, Ghassan J. Maghzal, Yung‐Chih Chen, David Cheng, Jihan Talib, Darren Newington, Ren Minqin, Saumitra Vajandar, Amy Searle, Ana Maluenda, Eva‐Lotte Lindstedt, Andrew Jabbour, Anthony J. Kettle, André Bongers, Carl Power, Erik Michaëlsson, Karlheinz Peter, Roland Stocker

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID

    A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID Yazar: Stefanie M. Bader, Dale J. Calleja, Shane M. Devine, Nathan W. Kuchel, Bernadine G.C. Lu, Xinyu Wu, Richard W. Birkinshaw, Reet Bhandari, Katie Loi, Rohan Volpe, Yelena Khakham, Amanda E. Au, T. Blackmore, Liana Mackiewicz, Merle Dayton, Jan Schaefer, L.R. Scherer, Angus T. Stock, James P. Cooney, Kael L. Schoffer, Ana Maluenda, Elizabeth A. Kleeman, Kathryn C. Davidson, Cody Allison, Gregor Ebert, Gong� Chen, Kasiram Katneni, Theresa Klemm, Ueli Nachbur, Smitha R. Georgy, Peter E. Czabotar, Anthony J. Hannan, Tracy L. Putoczki, Maria C. Tanzer, Marc Pellegrini, Bernhard C. Lechtenberg, Susan A. Charman, Melissa Call, Jeffrey P. Mitchell, Kym N. Lowes, Guillaume Lessène, Marcel Doerflinger, David Komander

    Baskı/Yayın Bilgisi 2025
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: